Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course

Francois M. Cady, Brian Patrick O'Neill, Mark E. Law, Paul A. Decker, David M. Kurtz, Caterina Giannini, Alyx B. Porter, Paul J. Kurtin, Patrick B. Johnston, Ahmet Dogan, Ellen D. Remstein

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Fingerprint Dive into the research topics of 'Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course'. Together they form a unique fingerprint.

Medicine & Life Sciences